Bionano Genomics, Inc. Annual Return On Equity in % from 2018 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Bionano Genomics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2024.
  • Bionano Genomics, Inc. Return On Equity for the quarter ending December 31, 2024 was -181 %, a 28.8% decline year-over-year.
  • Bionano Genomics, Inc. annual Return On Equity for 2024 was -181 %, a 28.8% decline from 2023.
  • Bionano Genomics, Inc. annual Return On Equity for 2023 was -141 %, a 199% decline from 2022.
  • Bionano Genomics, Inc. annual Return On Equity for 2022 was -47.1 %, a 125% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -181 -40.5 -28.8% Jan 1, 2024 Dec 31, 2024
2023 -141 -93.6 -199% Jan 1, 2023 Dec 31, 2023
2022 -47.1 -26.2 -125% Jan 1, 2022 Dec 31, 2022
2021 -20.9 +299 +93.5% Jan 1, 2021 Dec 31, 2021
2020 -320 +15.4K +98% Jan 1, 2020 Dec 31, 2020
2019 -15.7K -15.8K -18348% Jan 1, 2019 Dec 31, 2019
2018 86.1 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.